Figure S8 from The Ewing Family of Tumors Relies on BCL-2 and BCL-XL to Escape PARP Inhibitor Toxicity

Authors :: Anthony C. Faber
Sosipatros A. Boikos
Andrew J. Souers
Joel D. Leverson
Cyril H. Benes
Steven C. Smith
Yuki Kato Maves
Giovanna T. Stein
Maninderjit S. Ghotra
Marissa L. Calbert
Sheeba Jacob
Krista M. Powell
Colin M. Coon
Konstantinos V. Floros
Timothy L. Lochmann
Daniel A.R. Heisey
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: DNA damage is increased with the combination of olaparib and navitoclax

Full Text Access

Tools